D.35- COMMUNICATION OF CRITICAL LABORATORY RESULTS AND IOC 22-11.pdf

PDF 820 KB Posted

Attached to
Q201--Community Based Outpatient Clinic (CBOC): Cayuga County, NY (Auburn VA Clinic) of Syracuse VA Medical Center in VISN 2
Solicitation number
36C24224R0049
Issued by

About this file

This document is a policy that defines the required notification and documentation system for communicating critical laboratory results at the Syracuse VA Medical Center. The policy covers critical clinical laboratory results, heparin level testing, positive blood cultures, and communication of intraoperative consult diagnoses. It establishes protocols for notifying authorized providers within a 30-minute target timeframe and documenting all attempts to reach providers. The policy also addresses notification of other significantly abnormal test results. Overall responsibility resides with the Chief Pathologist. The policy will be reviewed annually and revised every 3 years.

The related federal contract opportunity is a Request for Proposal (RFP) 36C24224R0049 for Community Based Outpatient Clinic (CBOC) services to provide primary care to Veteran patients in Cayuga County, New York. The contract will cover a base year and nine one-year option periods. This is an unrestricted procurement with a single award. The NAICS code is 621498 All other Outpatient Care Centers with a $25.5 Million size standard.

View the file

Other files

File Type Posted
36C24224R0049 0002 VENDOR QA AMENDMENT NUMBER TWO_CAYUGA COUNTY CBOC.pdf PDF
D.51- VA ENTERPRISE FACILITY IT SUPPORT INFRASTRUCTURE STANDARDS.pdf PDF
36C24224R0049 0001 VENDOR QA AMENDMENT- CAYUGA COUNTY COMMUNITY BASED OUTPATIENT CLINIC.pdf PDF
D.11- WARD STOCK AND LAST 12 MONTHS OF ORDERS.pdf PDF
D.15- PROVISION OF SUICIDE PREVENTION SCREENINGS AND SAFETY PLANS IN AMBULATORY CARE SETTINGS- MAR 2023.pdf PDF
D.45- REACH VET STEPS- PROVIDER.pdf PDF
D.41- MINIMUM SCHEDULING EFFORT SOP _1-13-2022.pdf PDF
36C24224R0049- SOLICITATION FOR CAYUGA COUNTY NY COMMUNITY BASED OUTPATIENT CLINIC SERVICES.pdf PDF
D.16- MENTAL HEALTH NO SHOW AND CANCEL PROCEDURES- SEPT 2023.pdf PDF
D.26- MCP 11-146 MEDICATION RECONCILIATION AUG 2021.pdf PDF
D.40- ADMINISTRATIVE CLOSURE OF INCOMPLETE NOTES SOP.pdf PDF
D.47- COORDINATED CARE POLICY FOR TRAVELING VETERANS AUG 2021.pdf PDF
D.30- ORDERING LABORATORY TESTS PHLEBOTOMY AND SPECIMEN COLLECTION 20-03.pdf PDF
D.22- TELEHEALTH OPERATIONS MANUAL- CLINIC BASED.pdf PDF
D.32- ANCILLARY TESTING GUIDELINES.pdf PDF
D.12- US CENSUS DATA- VETERANS LIVING IN CAYUGA COUNTY BY PATIENT DEMOGRAPHICS.xlsx XLSX spreadsheet
D.20- HEALTH CARE SERVICES FOR WOMEN VETERANS.pdf PDF
D.49- SYRACUSE VAMC PRIVACY POLICY MCP 00-021.pdf PDF
D.33- ANTICOAGULATION CLINIC POLICIES AND PROCEDURES.pdf PDF
D.7- WAGE DETERMINATION 2015-4177 CAYUGA COUNTY REV. 27 DATED 07-22-2024.pdf PDF
D.25- TELEPRESENTER TMS TRAINING COURSES.pdf PDF
D.6- LIST OF ATTACHMENTS.pdf PDF
D.44- REACH VET ONE PAGE FLYER.pdf PDF
D.43- CBOC SAME DAY ACCESS PCMHI BHIP CC 6-27-2024.pdf PDF
D.21- REPORTING PATIENT SAFETY INCIDENTS IN THE JOINT PATIENT SAFETY REPORTING SYSTEM-JPSR.pdf PDF
D.50 VA SIGNAGE DESIGN MANUAL PG-18-10.pdf PDF
D.28- PATIENT MEDICAL RECORDS MANAGEMENT POLICY, MEDICAL RECORD STANDARDS.pdf PDF
D.24- FACILITY TELEHEALTH EMERGENCY PLAN AND EQUIPMENT AND SOFTWARE FAILURE PROCEDURE.pdf PDF
D.19- COMMUNICATING TEST RESULTS TO PROVIDERS AND PATIENTS DEC 2019.pdf PDF
D.5- KEY PERSONNEL LIST 02.docx DOCX document
D.39- NATIONAL STANDARDIZED SCHEDULER ONBOARDING- TRAINER GUIDE DEC 2022.pdf PDF
D.17- VHA DIRECTIVE 1003.04 VHA PATIENT ADVOCACY NOV 2023.pdf PDF
D.18- RIGHTS AND RESPONSIBILITIES OF VA PATIENTS AND RESIDENTS OF COMMUNITY LIVING CENTERS.pdf PDF
D.4- ORGANIZATIONAL CONFLICTS OF INTEREST.pdf PDF
D.8- DAVIS-BACON ACT NY20240101 CAYUGA COUNTY.pdf PDF
D.38- IMAGING- REPORTING OF IMAGING TEST RESULTS MCP 11-141 JUNE 2021.pdf PDF
D.14- EOC ASSESSMENT AND COMPLIANCE ROUNDING PROCESS GUIDE.pdf PDF
D.37- RADIOLOGY, HEALTH, SAFETY AND CONSENT PROCEDURES FOR STAFF AND PATIENTS- JULY 2023.pdf PDF
D.48- HIMS MEDICAL RECORD REVIEWS.pdf PDF
D.36- LAB MANUAL WITH COVER AND TABLE OF CONTENTS 2021.pdf PDF
D.13- CBOC CONTRACTOR LAB SUPPLY LIST- NOT SUPPLIED BY SYRACUSE VAMC.pdf PDF
D.23- HOME TELEHEALTH OPERATIONS MANUAL.pdf PDF
D.34- ANTICOAGULATION CLINIC PROCESSES SOP- APRIL 2022.pdf PDF
D.27- ELECTRONIC PRESCRIPTIONS FOR CONTROLLED SUBSTANCE PROCESSING, INPATIENT AND OUTPATIENT PRESCRIBING AND DISPENSING.pdf PDF
D.3- CONTRACTOR CERTIFICATION - IMMIGRATION AND NATIONALITY ACT OF 1952.pdf PDF
D.9- HEALTH CARE PERSONNEL INFLUENZA VACCINATION FORM.pdf PDF
D.29- PRE-TREATMENT AND TRANSPORTATION OF SOILED REUSABLE MEDICAL EQUIPMENT , REUSABLE NON-CRITICAL MEDICAL EQUIPMENT.pdf PDF
D.46- SUICIDE RISK IDENTIFICATION- RISK ID.pdf PDF
D.1- QUALITY ASSURANCE SURVEILLANCE PLAN - QASP.pdf PDF
D.31- SPECIMEN PROCEDURES SOP- JUNE 2022.pdf PDF
Show 40 more

Latest 50 of 53 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for ensuring printed copies are valid prior to use.

Department of Memorandum Veterans Affairs

Date: June 13, 2022 LABORATORY PROTOCOL

22-11

From: Chief Pathologist, P&LMS

Subj: COMMUNICATION OF CRITICAL LABORATORY RESULTS FOR THE CLINICAL

LABORATORY AND INTRAOPERATIVE CONSULTS

To: P&LMS Staff

PURPOSE:

1. The purpose of this policy is to define the required notification and documentation system for communicating laboratory results defined as critical by departmental policy.

2. The purpose of this policy is to meet or exceed the intent of all regulatory agencies.

POLICY:

• The Laboratory at Syracuse VA Medical Center defines Intra-Operative Consults (Frozen

Section) as critical tests. Critical tests require notification of an authorized provider regardless of the result of the test.

• In addition, specific clinical test results are defined as critical. Critical results require immediate notification of an authorized provider or staff member to facilitate prompt patient intervention.

• It is the responsibility of the authorized ordering provider to give and document appropriate patient care in response to the receipt of a critical laboratory result.

PROTOCOL:

A. Critical Clinical Laboratory Results:

1. Critical laboratory results will be defined and posted in each laboratory section, as well as in the laboratory manual. The document will be dated to indicate the last revision or review.

2. The technologist will attempt to contact the ordering physician and communicate the

"critical result” by telephone or electronic messaging via Microsoft Teams immediately after the result is confirmed. If there is no response within 10 minutes, please to try to communicate the results via a different method and/or a different authorized surrogate.

Attachment D.35 36C24224R0049

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for

3. All critical results given by telephone, must be read back to the laboratory technologist to ensure accuracy of communication. All critical results given by electronic messaging must be confirmed that the authorized person received the communication.

4. Documentation in the computer will include at least the following:

a. Technologist making the notification.

b. Test/analyte exceeding critical limits.

c. Authorized person receiving and reading back the result via telephone, their credentials, and their location, (as appropriate) or authorized person acknowledging and confirming receipt of critical via electronic messaging, their credentials, and their location, (as appropriate)

d. Date and time communication completed.

e. Method of communication (see examples below):

- for telephone use comment CVCR (critical value called -read back)

- for electronic messaging use comment CVEM (confirmed receipt of critical value via electronic messaging)

“Troponin Critical value called – reach back by Dr. Smith on 5/17/22 at 07:02/MST”

“Joe Smith, PA Confirmed receipt of critical value via electronic messaging of WBC on

5/17/22 at 07:02/MST”

5. When "No Significant Change" applies, as defined in sectional critical value protocols/policies, computer documentation still needs to include the “NSC” comment, the test/analyte exceeding critical limits, the date, and the initials of the responsible technologist (verifying technologist). The date on which the value was previously called may also be included.

6. In addition to calling the physician, all ICU critical values must be called to an ICU

Registered Nurse (RN).

7. When the ordering physician is not available, the following will apply:

a. EMERGENCY DEPARTMENT

i. The lab staff will call the ED and ask to speak to the ordering provider (MD, PA, or NP).

ii. If the ordering provider is unable to come to the phone, then the critical value will be reported to an available Registered Nurse (RN).

b. OPERATING ROOM

(Surgeons will be instructed to leave their pagers with the circulating nurse when they are in the operating room)

i. The lab staff will page the ordering physician when there is a critical value

ii. If the ordering physician is unable to come to the phone, the circulating

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for nurse will answer the page and the critical value will be reported to the nurse.

c. INTENSIVE CARE UNITS i The lab staff will call the ICU to give the critical value to an ICU Registered

Nurse (RN) only.

ii. At that time the nurse will tell the lab staff which physician should be called or paged.

iii. The lab staff will then page the physician so that the lab staff can report the critical value directly to the physician.

d. IN-HOUSE WARDS

i. The lab staff will call other providers on the patient’s Medicine Team, found on AMION and/or the current Medicine Team List, which is found on amion.com (login: vasyr).

ii. If the providers on the same team are unavailable, the lab staff will call the ward to ask which physician should be called or paged.

iii. The lab staff will then page the physician so that the lab staff can report the critical value directly to the physician.

**NOTE: Monday through Friday between 12:00 – 13:00 only, critical values for Medicine Team patients, Teams 1, 2, 3 and 4, must be called to the Medicine Team Attending and not to a

Resident or an Intern.**

e. IN-HOUSE PRIMARY CARE CLINICS

(Team Red, Team Blue, the Women’s Health Clinic, and the Specialty Clinics.)

i. The lab staff will attempt to contact the ordering primary care provider via electronic messaging, extension/pager or by calling:

x-56515 for Team Red and Team Blue x-54652 for WHC x-Please see phone list for all other clinics

ii. If the ordering provider is unavailable, the lab staff will ask the MSA who answers the phone, to be forwarded to the RN Case Manager that works with the ordering provider.

f. COUMADIN CLINIC

i. The lab staff will page the Coumadin Clinic pager 315-241-1035 for any of

Coumadin Clinic staff

ii. If there is not a response from the Coumadin Clinic pager, the lab staff will contact MSA who answers the phone at x-52615 and the call will be forwarded to an available provider. Electronic messaging may be used when there is no response from the Coumadin Clinic pager.

g. CBOCs (Rome, Auburn, Binghamton, Potsdam, Tompkins/Cortland, Oswego, and Watertown)

i. The lab staff will attempt to contact the ordering provider

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for

ii. If the ordering provider is unable to come to the phone or unavailable by electronic secure messaging then the lab staff will give the critical result to a

Registered Nurse (RN) only.

8. The lab staff will document ALL attempts that were made in contacting the ordering provider and/or the designated surrogate(s) in the computer.

9. In the rare event that an authorized person cannot be identified or reached on the phone, the ED Attending/ Night Float is authorized to take the result off-hours. During the day shift the result should be forwarded to the Quality Assurance Coordinator to continue the effort to contact an authorized provider.

B. Heparin Level: Anti-Xa (Heparin- Unfractionated) Critical Results:

1. UFH (Unfractionated Heparin) critical results will NOT be called to the ordering MD, PA, NP, or PharmD, as with other critical clinical laboratory results.

2. UFH critical results will be called to the Current Registered Nurse (RN) or the

Charge Nurse (RN), who are authorized ordering providers for this test.

3. The lab staff will document ALL attempts that were made in contacting the Current

Registered Nurse or the Charge Nurse.

4. In the rare event that the Current Registered Nurse or the Charge Nurse cannot be identified or reached on the phone, the Nursing Supervisor will be paged.

This will occur on both off-hours and the dayshift.

5. When the Current Registered Nurse and the Charge Nurse are both unavailable and the critical result(s) must be given to the Nursing Supervisor then a statement will be entered in the computer stating that the “Current RN and the Charge Nurse were both unavailable”. This documentation will show that due to circumstances out of the control of the laboratory a critical result had to be given to another RN, other than the authorized above stated (section B-2) personnel.

C. Positive Blood Cultures

1. If the patient is hospitalized at the time of the positive blood culture detection, refer to the protocol outlined in section A of this policy. The gram stain results for positive blood cultures should be called within one hour of detection during the dayshift hours and within two hours of detection during the off-hour shifts.

2. Refer to Laboratory Protocol 22-12 “Communication of Positive Blood Culture Results on Discharged Patients for the Clinical Laboratory” regarding the specific policy on the communication of positive blood cultures on discharged patients.

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for

QUALITY ASSURANCE:

With the approval of the Medical Executive Council a target of 30 minutes was established as the normal period within which communication of a critical test result should occur. It is understood that on occasion there will be difficulties contacting an authorized provider. For these instances the result will be reported and released, and the documentation of the final call will be added to the comment section of the result field later when the call is complete.

Efforts to communicate a critical test result that exceed 30 minutes from the time the result becomes available will be flagged in the comment section and monitored for improvement purposes. The time(s) the provider(s) was paged will be noted in the comment section of the result. The time the call or electronic method is actually complete, and the result read-back or confirmed receipt via electronic messaging will be documented in a separate comment. These accessions will be flagged for improvement purposes by using the expandable comment “NCV” which expands to “Notification of critical result exceeded established timeframe”. See the example below:

“Dr. Smith paged on 6/26/07 at 11:34 with PLT result by MST”

“PLT result called and read back by Dr. Smith at 12:45 on 6/26/07, MST”

NCV = “Notification of critical result exceeded time limit”

The QA Coordinator will be responsible for ensuring that all new employees are educated in the laboratory policy for the reporting and notification of critical results.

The list of critical values is maintained in the Laboratory Test Definitions File.

Other significantly abnormal clinical laboratory results (not defined as critical)

1. The notification of positive Hepatitis results are provided to the Infection Control Nurse and the established Hepatitis email groups at each VISN 2 site by E-Mail. The E-mail is printed and maintained for documentation. A View Alert is also sent via CPRS to the ordering provider.

2. Positive results for the Mono test are communicated via View Alert to the ordering provider.

3. Positive results for the Treponema Antibody are communicated (via View Alert) to the ordering provider and provided to the Infection Control Nurse or surrogate through E-mail.

4. An effort to alert the provider for significantly abnormal send-out test will be documented in the computer.

5. Positive results for Occult Blood/FIT are communicated to the floor/service and a View Alert is sent via CPRS. Positives for inpatients are called to the floor/service.

6. See Attachment 22-11: Microbiology Notification of Critical Tests and Significant Findings for Microbiology testing notification policy.

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for

Communication of Intraoperative Consult diagnosis:

1. Intra-operative consults will be defined as a critical anatomic test that requires rapid verbal diagnosis.

2. For IOC’s, the diagnosis will be repeated back by the receiving staff via telephone.

3. The pathologist / resident making the call will document their name as the person placing the call, who was called, and the date and time the call was complete on the final report.

4. When physicians/providers are notified of a new malignancy P-code 11301 will be used. The confirmation of new malignancy by second pathologist will be used and P-code 11300 will be used.

REFERENCE:.

SOP 119-001: Heparin Dosing via Weight Based Heparin Dosing Nomogram, August 2021

RESCISSION/S: 05-09, 06-04, 07-02, 09-01, 12-01, 15-01, 16-11, 19-11

RESPONSIBILITY: Overall responsibility resides with the Chief Pathologist, P&LMS

REVIEW & REVISION SCHEDULE:

• Annual review by Chief Pathologist (date and initials below)

• Revision every 3 years: Due 2025

Seena Kumar, MD

Chief Pathologist, Pathology and Laboratory Medicine 113

The master document is controlled electronically on the D&T drive. Printed copies of this document are not controlled and users are responsible for

22-11: Communication of Critical Laboratory Results for the Clinical Laboratory and

Intraoperative Consults

Date Annual Review Complete: Initials of Reviewer (Lead Pathologist)

Review Due 2023

Review Due 2024

REVISION DUE 2025

File details come from the government source that posted it. Updated .